Alendronate Sodium
Brand names,
Alendronate Sodium
Analogs
Alendronate Sodium
Brand Names Mixture
Alendronate Sodium
Chemical_Formula
C4H13NO7P2
Alendronate Sodium
RX_link
http://www.rxlist.com/cgi/generic/alendron.htm
Alendronate Sodium
fda sheet
Alendronate Sodium
msds (material safety sheet)
Alendronate Sodium
Synthesis Reference
M. I. Kabachnik et al., Bull. Acad. Sci. USSR,.27, 374 (1978)
Alendronate Sodium
Molecular Weight
249.096 g/mol
Alendronate Sodium
Melting Point
233 - 235 oC
Alendronate Sodium
H2O Solubility
1mg/L
Alendronate Sodium
State
Solid
Alendronate Sodium
LogP
-3.198
Alendronate Sodium
Dosage Forms
Tablets (6.53, 13.05, 45.68, 52.21 or 91.37 mg of alendronate monosodium salt trihydrate)
Alendronate Sodium
Indication
For the treatment and prevention of osteoporosis in women and Paget's disease of bone in both men and women.
Alendronate Sodium
Pharmacology
Alendronate, a second-generation bisphosphonate is the first member of a group of drugs which strengthens bone. Alendronate is used to reduce hypercalcemia in tumor-induced bone disease, to treat corticosteroid-induced osteoporosis and Paget's disease, and to prevent osteoporosis in postmenopausal women.
Alendronate Sodium
Absorption
Relative to an intravenous (IV) reference dose, the mean oral bioavailability of alendronate in women was 0.7% for doses ranging from 5 to 40 mg when administered after an overnight fast and two hours before a standardized breakfast. Oral bioavailability of the 10 mg tablet in men (0.59%) was similar to that in women (0.78%) when administered after an overnight fast and 2 hours before breakfast.
Alendronate Sodium
side effects and Toxicity
Alendronate can damage the esophagus both by toxicity from the medication itself and by nonspecific irritation secondary to contact between the pill and the esophageal mucosa, similar to other cases of "pill esophagitis."
Alendronate Sodium
Patient Information
Alendronate Sodium
Organisms Affected
Humans and other mammals